Data Science Funding Announcements & Notices

Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.

Title FOA Organization Release Date Expire Date Purpose
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) PAR-18-893 NCI This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical… More
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) RFA-CA-21-015 NCI The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to… More
Proteome Characterization Centers (PCCs) for Clinical Proteomic Tumor Analysis Consortium (U24 Clinical Trial Not Allowed) RFA-CA-21-023 NCI This Funding Opportunity Announcement (FOA) supports the NCI Clinical Proteomic Tumor Analysis Consortium (CPTAC) managed by theOffice of Cancer Clinical Proteomics Research (OCCPR). CPTAC leverages… More
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required) PAR-20-305 NCI Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPORE).… More
Notice of National Cancer Institute (NCI) Participation in PAR-20-100 Genomic Community Resources (U24 Clinical Trial Not Allowed) NOT-CA-20-027 NCI N/A Notice National Cancer Institute NCI) Participation PAR-20-100 Genomic Community Resources U24 Clinical Trial Allowed)” Notice Number: NOT-CA-20-027 Key Dates Release Date: January 28, 2020 Related… More
Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) RFA-CA-20-046 NCI Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to advance our understanding of: the modes of transmission of Kaposi sarcoma-associated herpesvirus (… More
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional) PAR-19-352 NCI This Funding Opportunity Announcement (FOA) invites applications for intervention research designed to support caregivers of adult cancer patients. Interventions supported by this FOA are intended to… More
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) RFA-CA-21-014 NCI The goal of this FOA is to advance cancer model systems that recapitulate human immunity in the tumor microenvironment to improve the predictivity of immuno-oncology studies. Proposed research… More
Notice of Availability of Administrative Supplements for Integrative Data Analysis to extend Research in Cancer Control and Population Sciences (Admin Supp Clinical Trial - Optional) NOT-CA-18-087 NCI N/A Notice Availability Administrative Supplements Integrative Data Analysis Extend Research Cancer Control Population Sciences Admin Supp Clinical Trial - Optional) Notice Number: NOT-CA-18-087 Key… More
Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01 Clinical Trial Not Allowed) PAR-19-361 NCI This Funding Opportunity Announcement (FOA) invites applications to establish research teams of the Small-Cell Lung Cancer (SCLC) Consortium to conduct research whose overall goals are: 1) to improve… More
Updated: